Investment
Features
FeesSafety
Academy
More
Pluang+

Compare JPMorgan Chase & Co (JPM) vs Marsh & McLennan Companies, Inc. (MRSH) Price & Performance

JPMorgan Chase & CoTrade
Marsh & McLennan Companies, Inc.Trade

Price performance (Past 24H)

Key statistics

JPMorgan Chase & Co vs Marsh & McLennan Companies, Inc. — how do they compare? JPMorgan Chase & Co trades at $333.38 (market cap $880.98B), while Marsh & McLennan Companies, Inc. trades at $175.94 (market cap $84.31B). The key difference: JPMorgan Chase & Co is far larger — about 10.4× Marsh & McLennan Companies, Inc.'s market cap, and Marsh & McLennan Companies, Inc. pays the higher dividend (2.24%). Which is the better fit depends on your goals — on Pluang, investors hold JPMorgan Chase & Co for 127 Days and Marsh & McLennan Companies, Inc. for 109 Days on average.

JPMMRSH
Market Cap
$880.98B$84.31B
Volume
7,721,6613,948,947
Sector
FinancialsFinancials
52-Week High
$365.18$207.02
52-Week Low
$282.84$157.32
Typical Hold Time
127 Days109 Days
Enterprise Value
$1.82T$104.99B
Dividend Yield
1.99%2.24%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

JPMorgan Chase & Co

JPMorgan Chase (JPM) trades at $332.99, up 1.03% today, with a bearish technical signal but strong fundamentals. Recent earnings beat expectations in Q1 and Q2 2026, with revenue growth from $181.85B in 2025 to a projected $194.9B in 2026. The stock shows a P/E of 14.2 and ROE of 18.43%, supported by a 'Moderate Buy' analyst consensus and a $373.18 price target. News highlights CEO Jamie Dimon's economic warnings and upcoming Q1 earnings as key catalysts.

Outlook: JPM offers value with solid profitability and analyst upside, but risks include geopolitical tensions and cybersecurity threats. The stock's bearish technicals near support at $327 suggest caution, though institutional buying and high ROE provide stability. Investors should weigh strong fundamentals against macroeconomic headwinds highlighted in recent news.

Marsh & McLennan Companies, Inc.

MRSH trades at $176.16, up 1.44% today, with a bullish technical signal and consistent earnings beats in recent quarters. The company completed the acquisition of Accel Holdings on October 2, 2026, expanding its advisory footprint. Revenue grew to $27.0B in 2025, with a net income margin of 15.41%, while valuation ratios like P/E of 21.57 and ROE of 25.72% reflect strong profitability. Analysts maintain a consensus price target of $202.71, though sentiment is mixed with a 'Hold' rating from most.

The outlook for MRSH is positive due to earnings momentum and strategic acquisitions, but risks include competitive pressures and potential margin compression. Upside remains if the company meets Q3 2026 EPS expectations of $1.97, supported by solid cash flow trends. Investors should weigh the high P/B ratio of 5.55 against growth prospects in the reinsurance sector.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

JPM
30% Buy70% Sell
Avg holding period · 127 Days
MRSH
100% Buy0% Sell
Avg holding period · 109 Days

Top news

Latest headlines on both assets

About JPMorgan Chase & Co

JPMorgan Chase & Co. provides global financial services and retail banking. The Company provides services such as investment banking, treasury and securities services, asset management, private banking, card member services, commercial banking, and home finance. JP Morgan Chase serves business enterprises, institutions, and individuals.

Read more on JPM →

About Marsh & McLennan Companies, Inc.

Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).

Read more on MRSH →